Related Experiment Video
Updated: Jul 15, 2026
05:08
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Can irradiated tumors take NO for an answer?
Randall S Johnson1, L Eric Huang
1Molecular Biology Section, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
Molecular Cell
|May 1, 2007
Summary
Ionizing radiation stabilizes hypoxia-inducible factor 1alpha (HIF-1alpha) in tumors. This occurs via S-nitrosylation, mediated by nitric oxide (NO) from activated macrophages, even without low oxygen conditions.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Hypoxia-inducible factor 1alpha (HIF-1alpha) is a key regulator of cellular response to low oxygen (hypoxia).
- Tumor microenvironments often exhibit complex interactions between radiation, immune cells, and oxygen levels.
- Nitric oxide (NO) plays diverse roles in cancer biology and inflammation.
Purpose of the Study:
- To investigate the mechanism by which ionizing radiation affects HIF-1alpha stability in normoxic tumor tissues.
- To determine the role of nitric oxide (NO) and activated macrophages in this process.
Main Methods:
- The study by Li et al. (2007) in Molecular Cell focused on analyzing the molecular pathways involved.
- Investigated the S-nitrosylation of HIF-1alpha in response to ionizing radiation.
- Examined the source of nitric oxide (NO) in the tumor microenvironment.
Main Results:
- Ionizing radiation was found to stabilize HIF-1alpha even in the presence of normal oxygen levels (normoxia).
- This stabilization is mediated by S-nitrosylation of HIF-1alpha.
- The nitric oxide (NO) responsible for S-nitrosylation is generated by neighboring activated macrophages.
Conclusions:
- Ionizing radiation can stabilize HIF-1alpha in normoxic tumor tissues through a macrophage-dependent NO-mediated S-nitrosylation pathway.
- This finding reveals a novel mechanism linking radiation, inflammation, and oxygen-independent HIF-1alpha stabilization in cancer.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...